Next, B2M expression in tumor was quantified and explored for associations with survival, by QIF on a second, independent, validation cohort of R/M HNSCC cases (Yale cohort, YTMA523; Supplementary Fig. S4A). The gene discussed is B2M; the disease is head and neck squamous cell carcinoma.